|Articles|November 14, 2018

Ways to Reduce Sample Size In Clinical Trials

To Learn more, visit Statsols.com.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

What Has to Happen on the Back End Before Real-Time Data Streaming Becomes Useful

ByRaviv Pryluk, PhD,Andy Studna, Senior Editor

July 28th 2026

ACT Brief: Data Readiness Gap in Continuous Monitoring, Workflow-Centric AI Deployment, and First-in-Class ADHD Mechanism

ByAndy Studna, Senior Editor

July 28th 2026

Workflow in the Age of AI

ByNorman M. Goldfarb

July 27th 2026

What the "Dead Time" Problem Actually Is and Why It Matters for Real-Time Monitoring

ByRaviv Pryluk, PhD,Andy Studna, Senior Editor

July 27th 2026

ACT Brief: Inspection Readiness Throughout Lifecycle, AI Churn and Operational Discipline, and Global Trial Stakeholder Alignment

ByAndy Studna, Senior Editor

July 27th 2026

Ways to Reduce Sample Size In Clinical Trials

Related Content

What Has to Happen on the Back End Before Real-Time Data Streaming Becomes Useful

ACT Brief: Data Readiness Gap in Continuous Monitoring, Workflow-Centric AI Deployment, and First-in-Class ADHD Mechanism

Workflow in the Age of AI

What the "Dead Time" Problem Actually Is and Why It Matters for Real-Time Monitoring

ACT Brief: Inspection Readiness Throughout Lifecycle, AI Churn and Operational Discipline, and Global Trial Stakeholder Alignment

Trending on Applied Clinical Trials Online

Workflow in the Age of AI

The AI Churn Trap in Life Sciences and How to Break It

ACT Brief: Inspection Readiness Throughout Lifecycle, AI Churn and Operational Discipline, and Global Trial Stakeholder Alignment

ACT Brief: Execution Failures and Upstream Origins, European Data Governance Reshaping CROs, and Phase-Dependent Trial Competition

What the "Dead Time" Problem Actually Is and Why It Matters for Real-Time Monitoring